首页>
外国专利>
Biomarkers for human monocyte myeloid-derived suppresor cells
Biomarkers for human monocyte myeloid-derived suppresor cells
展开▼
机译:人类单核细胞来源的抑制细胞的生物标记
展开▼
页面导航
摘要
著录项
相似文献
摘要
A method for diagnosing an increased risk of a cancer in a subject includes the steps of obtaining a blood sample from the subject and determining, in the blood sample, a level of two or more of the polypeptides selected from the group consisting of VNN2, KCNJ15, SERPINB2, CREB5, ICAM3, NFE2, MNDA, PXN, FCAR, TSHZ3, NRG1, ALOX5AP, PAD14, PAD12, QPC, VNN1, SERPINB10, CLEC4D, TREM1, CLEC4E, CD82, MGAM, TMEM45B and VNN3, wherein an increase in the level of two or more of the polypeptides compared to a control level is indicative of an increased risk of cancer in the subject.
展开▼